[Cystic pancreatic tumors]

Area of Science:

• Gastroenterology
• Surgical Oncology
• Pathology

Context:

• Cystic tumors of the pancreas (CTP) represent a rare but significant group of pancreatic neoplasms, accounting for less than 5% of all pancreatic tumors.
• Epithelial-origin CTPs constitute 90% of all CTPs and are classified into benign, potentially malignant, and malignant subgroups.
• Accurate preoperative differentiation of CTP subtypes is critical for appropriate patient management and surgical decision-making.

Purpose:

• To review the classification and clinical significance of epithelial cystic tumors of the pancreas.
• To highlight the importance of preoperative diagnostic modalities, including cytologic examination and cyst fluid analysis.
• To discuss the evolving indications for surgical resection in CTP management.

Summary:

• Epithelial CTPs are categorized into serous cystadenomas (benign), mucinous cystadenomas and intraductal papillary mucinous tumors (IPMTs) with malignant potential, and malignant tumors (cystadenocarcinoma, malignant IPMTs).
• Serous cystadenomas typically do not require surgery unless symptomatic, whereas mucinous and malignant CTPs necessitate radical resection.
• Cytologic examination and cyst fluid biochemical assays are vital for preoperative diagnosis, guiding treatment strategies for these pancreatic neoplasms.

Impact:

• Improved preoperative diagnostic accuracy for CTPs can lead to more tailored and effective treatment strategies.
• Enhanced understanding of CTP biology influences surgical indications, potentially improving patient outcomes.
• Awareness of the risks associated with postoperative morbidity and mortality is essential when considering surgical intervention for CTPs.